铭依眼科六载:以ICL匠心定制，定义品质视觉

近视，不应是束缚视野的枷锁。铭依眼科，作为专注眼健康的守护者，始终致力于将全球领先的视力矫正方案带给近视患者朋友。其中，ICL（可植入式晶体眼镜，或“眼内镜”）技术凭借其卓越的安全性、有效性与长期稳定性，成为铭依眼科为近视人群及追求卓越视觉品质人群提供的核心解决方案。

全球信赖，安全见证：ICL的30载卓越历程

自1993年首例植入至今，ICL技术已拥有超过30年的成熟应用历史，全球累计植入量突破300万片，这是其安全性的有力全球背书。其核心奥秘在于独特的Collamer?材料——一种具有优异生物相容性的专利材质，30年的临床实践充分验证了其在眼内的长期友好共存。同时，ICL提供绝佳的光学成像质量，其“轻薄柔软”的特性也大大提升了手术的可操作性与患者体验，使其成为拥有最长时间随访记录的有晶状体眼人工晶状体。近千篇严谨的临床研究（超半数源自中国）共同构筑了ICL在安全性、有效性及产品性能方面的坚实科学基础。

长期实证，稳定无忧：ICL的卓越临床表现

多项权威的长期随访研究（3-5年及以上）为ICL的优异表现提供了强有力的数据支撑：

• 安全可靠：研究显示，ICL术后的安全指数（平均术后矫正视力/平均术前矫正视力）始终大于1，直观证明了手术的高度安全性。

• 效果卓越且稳定： 复旦大学附属眼耳鼻喉科医院周行涛教授和王晓瑛教授团队的重要研究表明，在5年随访中，ICL组在安全性指数（1.20±0.19 vs 1.12±0.20）和有效性指数（1.03±0.20 vs 0.96±0.20）上均显著优于SMILE手术组。同时，ICL组术后裸眼视力达到20/20及以上的比例（81.3% vs 67.7%）以及近视度数稳定在±1.00D范围内的比例（96.9% vs 90.3%）也更高。

• 长期稳定无忧：大量长期研究数据一致证实，ICL术后患者的眼压、角膜内皮细胞计数及晶体拱高均保持长期稳定。更值得关注的是，ICL植入不影响未来可能需要的白内障手术中人工晶体（IOL）的计算与选择，为患者保留了更多未来的治疗可能性。

铭依匠心：六年专注，定制您的专属“视”界

在铭依眼科，我们深知每一双眼睛都是独一无二的艺术品。我们第一批ICL术后六年的患者随访数据显示，整体满意度高达99.8%。这份近乎完美的答卷，源于铭依眼科六年来始终如一坚持“一眼一方案，个性化定制”的理念。

在铭依，ICL远不止视力矫正，不是“流水线”作业

1.精密测量：参数精确至0.1毫米

2.专业团队：由检查团队、服务团队与三甲手术专家共同研判

3.精准匹配:从不同组合的ICL方案中用专业与经验锁定专属方案

4.持续保驾护航：铭依提供完善的手术保障与术后随访体系

5.卓越体验：首批患者6年随访满意度99.8%

铭依眼科，以全球验证的ICL技术与极致定制的匠心服务，为您照亮独一无二的人生旅程，清晰见证世界的每一份精彩。

参考文献

1. Packer M. The Implantable Collamer Lens with a central port: review of the literature. Clin Ophthalmol. 2018 Nov 27;12:2427-2438.

2. Montés-Micó R, Ruiz-Mesa R, Rodríguez-Prats JL, Ta?á-Rivero P. Posterior-chamber phakic implantable collamer lenses with a central port: a review. Acta Ophthalmol. 2021 May;99(3):e288-e301.

3. Wannapanich T, Kasetsuwan N, Reinprayoon U. Intraocular Implantable Collamer Lens with a Central Hole Implantation: Safety, Efficacy, and Patient Outcomes. Clin Ophthalmol. 2023 Mar 24;17:969-980. 

4. Sánchez-Ventosa á, Cano-Ortiz A, González Cruces T, Villalba González M, Membrillo A, Villarrubia A. Analysis after posterior chamber phakic intraocular lens implantation: 17- to 19-year follow-up study. J Cataract Refract Surg. 2024 Aug 1;50(8):816-821.

5. Chung B, Choi JY, Kang DSY, Kim K, Kim BY, Kim TI. Ten-Year Clinical Outcomes of V4c Implantable Collamer Lens Implantation: Longitudinal Analysis of Visual Acuity, Endothelial Cell Density, and Vault Dynamics. Am J Ophthalmol. 2025 Jan;269:1-10. 

6. Alfonso-Bartolozzi B, Fernández-Vega-Cueto L, Lisa C, Palacios A, Madrid-Costa D, Alfonso JF. Ten-year follow-up of posterior chamber phakic intraocular lens with central port design in patients with low and normal vault. J Cataract Refract Surg. 2024 May 1;50(5):441-447. 

7. Zhan B, Huang Y, Chen X, Aruma A, Cheng M, Wang X, Zhou X. Comparison of long-term visual quality after keratorefractive lenticule extraction and implantable collamer lens V4c for high myopia. J Cataract Refract Surg. 2024 Nov 1;50(11):1157-1164. 

8. Wan Q, Chen L, He P, Wei R, Ma K, Yin H, Tang J, Deng YP. Five years comparation of efficacy and safety after ICL-V4c implantation for high and super high myopia correction. Ann Med. 2025 Dec;57(1):2448282.

9. Lwowski C, Van Keer K, Ruscher T, Van Keer L, Shajari M, Kohnen T. Five-year follow-up of a posterior chamber phakic intraocular lens with a central hole for correction of myopia. Int Ophthalmol. 2023 Dec;43(12):4933-4943.

10. Chen X, Li L, Rao J, Chen YX, Gao Y, Huang RX, Zhou QZ. Long-term observation on safety and visual quality of implantable collamer lens V4c implantation for myopia correction: a 5-year follow-up. Int J Ophthalmol. 2023 Jul 18;16(7):1123-1129.

11. Chen X, Wang X, Xu Y, Cheng M, Han T, Wang X, Zhou X. Long-term Comparison of Vault and Complications of Implantable Collamer Lens with and without a Central Hole for High Myopia Correction: 5 Years. Curr Eye Res. 2022 Apr;47(4):540-546.

12. Kamiya K, Shimizu K, Takahashi M, Ando W, Hayakawa H, Shoji N. Eight-Year Outcomes of Implantation of Posterior Chamber Phakic Intraocular Lens With a Central Port for Moderate to High Ametropia. Front Med (Lausanne). 2021 Dec 16;8:799078.

13. Fernández-Vega-Cueto L, Alfonso-Bartolozzi B, Lisa C, Madrid-Costa D, Alfonso JF. Seven-year follow-up of posterior chamber phakic intraocular lens with central port design. Eye Vis (Lond). 2021 Jun 11;8(1):23.

14. Chen X, Wang X, Xu Y, Cheng M, Han T, Niu L, Wang X, Zhou X. Five-year outcomes of EVO implantable collamer lens implantation for the correction of high myopia and super high myopia. Eye Vis (Lond). 2021 Nov 9;8(1):40.

15. Yang W, Zhao J, Zhao J, Shen Y, Niu L, A R, Wang X, Zhou X. Changes in anterior lens density after Implantable Collamer Lens V4c implantation: a 4-year prospective observational study. Acta Ophthalmol. 2021 May;99(3):326-333.

16. Yang W, Zhao J, Sun L, Zhao J, Niu L, Wang X, Zhou X. Four-year observation of the changes in corneal endothelium cell density and correlated factors after Implantable Collamer Lens V4c implantation. Br J Ophthalmol. 2021 May;105(5):625-630.

17. Zhao J, Yang W, Zhao J, Shen Y, Sun L, Han T, Wang X, Yao P, Zhou X. A four-year observation of corneal densitometry after implantable collamer lens V4c implantation. Ann Transl Med. 2021 Apr;9(7):536.

18. Alfonso JF, Fernández-Vega-Cueto L, Alfonso-Bartolozzi B, Montés-Micó R, Fernández-Vega L. Five-Year Follow-up of Correction of Myopia: Posterior Chamber Phakic Intraocular Lens With a Central Port Design. J Refract Surg. 2019 Mar 1;35(3):169-176.

19. Wei R, Li M, Aruma A, Knorz MC, Yang D, Yu Y, Wang X, Choi J, Yao P, Zhou X. Factors leading to realignment or exchange after implantable collamer lens implantation in 10?258 eyes. J Cataract Refract Surg. 2022 Oct 1;48(10):1190-1196.

20. Amro M, Chanbour W, Arej N, Jarade E. Third- and fourth-generation formulas for intraocular lens power calculation before and after phakic intraocular lens insertion in high myopia. J Cataract Refract Surg. 2018 Nov;44(11):1321-1325.

21. Chen X, Zhang D, Liu Z, Liu Y, Cai H, Wu Q, Zhang Y. Effect of Implantable Collamer Lens on Anterior Segment Measurement and Intraocular Lens Power Calculation Based on IOLMaster 700 and Sirius. J Ophthalmol. 2021 Dec 21;2021:8988479.

22. Ouchi M. Evaluation of impact of posterior phakic IOL implantation on biometry and effectiveness of concomitant use of anterior segment OCT on IOL power calculation for cataract surgery. J Cataract Refract Surg. 2022 Jun 1;48(6):657-662.

23. Zhang D, Yang M, Liu Z, Cai H, Chen X, Zhang C. The effect of implantable collamer Lens V4c on ocular biometric measurements and intraocular lens power calculation based on Pentacam-AXL and IOLMaster 500. BMC Ophthalmol. 2022 Nov 5;22(1):421.

24. 迪力阿热木·艾力哈木,高晓唯,李钊,等. ICL-V4c植入对人工晶状体度数计算的影响[J]. 中华眼视光学与视觉科学杂志,2022,24(10)：767-772.

25. Zeng Z, Zhu M, Zhang G. Accuracy of intraocular lens calculation formulas based on swept-source OCT biometer in cataract patients with phakic intraocular lens. BMC Ophthalmol. 2024 Aug 5;24(1):326.

26. Arrevola-Velasco L, Beltrán J, Rumbo A, Nieto R, Druchkiv V, Martínez de la Casa JM, Ruiz-Moreno JM. Ten-year prevalence of rhegmatogenous retinal detachment in myopic eyes after posterior chamber phakic implantable collamer lens. J Cataract Refract Surg. 2023 Mar 1;49(3):272-277.

27. Patient Survey, STAAR Surgical ICL Data Registry, 2018.

28. Nakamura T, Isogai N, Kojima T, Yoshida Y, Sugiyama Y, Tanaka Y, Ichikawa K. Long-term In Vivo Stability of Posterior Chamber Phakic Intraocular Lens: Properties and Light Transmission Characteristics of Explants. Am J Ophthalmol. 2020 Nov;219:295-302

郑重声明：此文内容为本网站转载企业宣传资讯，目的在于传播更多信息，与本站立场无关。仅供读者参考，并请自行核实相关内容。